Sonoma Pharmaceuticals, Inc. announced on October 22, 2024, an amendment to its distribution agreement with a leading global healthcare distributor. This amendment expands the marketing and distribution of Sonoma's wound care products into Canada.
This new agreement builds upon a previous distribution partnership established on August 19, 2024, which focused on the marketing and distribution of wound care products in the United States through hospital systems and other healthcare channels.
The expansion into Canada allows Sonoma to leverage its partner's established network to increase the penetration and sales volume of its Microcyn technology-based wound care products in a new international market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.